What is Torrent Pharmaceuticals Limited's (TORNTPHARM.NS) StockRank?

MoatMap's StockRank for Torrent Pharmaceuticals Limited (TORNTPHARM.NS) is 52/100, with a Hold signal. This is a composite score combining Quality (58), Value (16), and Momentum (73) factor ranks across MoatMap's universe of 25,000+ stocks.

Does Torrent Pharmaceuticals Limited have an economic moat?

Torrent Pharmaceuticals Limited (TORNTPHARM.NS) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Torrent Pharmaceuticals Limited a buy, hold, or sell?

MoatMap's current signal for Torrent Pharmaceuticals Limited (TORNTPHARM.NS) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.

What sector is Torrent Pharmaceuticals Limited in?

Torrent Pharmaceuticals Limited (TORNTPHARM.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

TORNTPHARM.NS

HoldPremium Grower

Torrent Pharmaceuticals Limited · Healthcare · India · $19.9B · Avg Vol: $21M/d

StockRank

Get insider-trade alerts

P/E (TTM)

78.9x

ROE

25.8%

D/E

0.9x

Dividend %

0.8%

COMPANY DESCRIPTION

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.

FINANCIAL SUMMARY (INR)

Year	2023	2024	2025	2026	CAGR	TTM	2027E	2028E	Fwd CAGR
Revenue	94.6B	105.6B	113.2B	137.5B	13.3%	157.8B	194.8B	219.2B	26.2%
EPS (INR)	36.79	48.94	56.47	63.92	20.2%	62.71	65.43	90.38	18.9%
Shares	338.4M	338.4M	338.4M	338.4M	0.0%	380.4M	—	—	—
Debt	53.7B	40.2B	32.0B	150.3B	40.9%	150.8B	—	—	—
Equity	62.0B	68.6B	75.9B	83.9B	10.6%	—	—	—	—
Op CF	23.7B	32.7B	25.9B	30.2B	8.5%	30.3B	—	—	—
Inv CF	-24.2B	-1.7B	-5.4B	-127.1B	—	—	—	—	—
Fin CF	773.6M	-27.8B	-23.0B	101.5B	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+1.2%

SMA 50SMA 200

$51.66

RSI (14)

45.4

52W High

$55.01

From 52W High

0.9%

SCORE BREAKDOWN

Quality

ROIC

9.7%70.6

ROE

25.8%93.2

GP/Assets

27.0%57.7

Op. Margin

21.8%85.0

FCF/Assets

5.3%71.4

Piotroski

431.0

Int. Cover

5.5x53.0

D/E Ratio

0.85x17.0

Current Ratio

1.13x14.4

Value

P/E (TTM)

78.9x12.5

EV/EBITDA

39.4x15.6

P/FCF

80.7x18.6

P/B

19.9x5.8

P/S

11.9x23.3

Div Yield

0.8%22.9

Momentum

52W High %

94%91.7

RS 6M

16%77.6

SMA 50/200

1.14x81.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+49%54.2

Q Growth

3%40.5

FUNDAMENTALS

Market Cap

$19.9B

P/E (Forward)

52.9x

Gross Margin

76.0%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TORNTPHARM.NS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
TORNTPHARM.NS	Torrent Pharmaceuticals Limited(you)	$19.9B	52	Hold
DRREDDY.NS	Dr. Reddy's Laboratories Limited	$10.1B	50	Hold
ZYDUSLIFE.NS	Zydus Lifesciences Limited	$12.1B	68	Buy
CIPLA.NS	Cipla Limited	$11.8B	68	Buy
DIVISLAB.NS	Divi's Laboratories Limited	$26.8B	73	Buy
MANKIND.NS	Mankind Pharma Limited	$10.1B	69	Buy
WOCKPHARMA.NS	Wockhardt Limited	$3.8B	54	Hold
LAURUSLABS.NS	Laurus Labs Limited	$11.1B	75	Buy
ALKEM.NS	Alkem Laboratories Limited	$6.5B	69	Buy
PPLPHARMA.NS	Piramal Pharma Limited	$3.2B	58	Hold

Peer medians: ROE 11.8% · P/E 42.5x · Gross margin 59.4%

Torrent Pharmaceuticals Limited (TORNTPHARM.NS): Stock Score Summary

Torrent Pharmaceuticals Limited (TORNTPHARM.NS) has a MoatMap StockRank of 52/100 based on Quality (58/100), Value (16/100), and Momentum (73/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$51.66
Market Cap	$19.9B
P/E (TTM)	78.88
P/E (Forward)	52.92
Price/Book	19.89
Return on Equity	25.8%
Return on Invested Capital	9.7%
Debt/Equity	0.85x
Gross Margin	76.0%
Operating Margin	21.8%
Revenue Growth	54.8%
Dividend Yield	0.8%
Free Cash Flow	$247M

Torrent Pharmaceuticals Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (India).

Frequently Asked Questions

What is Torrent Pharmaceuticals Limited’s (TORNTPHARM.NS) StockRank?: MoatMap’s StockRank for Torrent Pharmaceuticals Limited (TORNTPHARM.NS) is 52/100, with a Hold signal. It is a composite of Quality (58), Value (16), and Momentum (73) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Torrent Pharmaceuticals Limited have an economic moat?: Torrent Pharmaceuticals Limited (TORNTPHARM.NS) has a Quality factor score of 58/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Torrent Pharmaceuticals Limited a buy, hold, or sell?: MoatMap’s current signal for Torrent Pharmaceuticals Limited (TORNTPHARM.NS) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Torrent Pharmaceuticals Limited in?: Torrent Pharmaceuticals Limited (TORNTPHARM.NS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (India).